Hudson Bay Capital Management
IMMU

Hudson Bay Capital Management’s Immunomedics Inc IMMU Stock Holding History

Hudson Bay Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-450,000
Closed -$38.3M – 857
2020
Q3 		$38.3M Buy
+450,000
New +$22.8M 0.57% 24
2018
Q2 		– Sell
-20,000
Closed -$292K – 1039
2018
Q1 		$292K Buy
+20,000
New +$327K 0.01% 709

Hudson Bay Capital Management's IMMU Position: Q4 2020 in Review

Hudson Bay Capital Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 450,000 shares — an estimated $38.3M sold.

Hudson Bay Capital Management first reported a position in IMMU in Q1 2018 and held it in 2 quarters. The position peaked at $38.3M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Hudson Bay Capital Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Hudson Bay Capital Management sold 450,000 Immunomedics Inc shares in Q4 2020, an estimated $38.3M.
  • Hudson Bay Capital Management first reported a position in Immunomedics Inc in Q1 2018 and held it in 2 quarters.
  • Hudson Bay Capital Management's Immunomedics Inc position peaked at $38.3M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Hudson Bay Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.